Lipid transport and the availability of insulin.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D003677:Deficiency Diseases / Q000150:complications; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005234:Fatty Liver / Q000209:etiology; D005953:Glycogen Storage Disease Type I / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000378:metabolism; D007003:Hypoglycemia / Q000209:etiology; D007328:Insulin / Q000172:deficiency / Q000378:metabolism / Q000502:physiology; D007330:Insulin Antibodies / Q000008:administration & dosage; D007657:Ketone Bodies / Q000378:metabolism; D050356:Lipid Metabolism; D008053:Lipid Mobilization; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007330:Insulin Antibodies; D007657:Ketone Bodies; D008079:Lipoproteins, VLDL; D014280:Triglycerides